Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about NTLA
Recent news which mentions NTLA
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Analyst Ratings for Intellia Therapeutics
May 24, 2022
Tickers
NTLA
Tags
Market News
Benzinga
BZI/AAR
From
Benzinga
Why Editas Medicine's Shares Fell 28.9% This Week
May 13, 2022
Tickers
CRSP
EDIT
NTLA
Tags
CRSP
Recent Press Releases
Market News
From
Motley Fool
10 Biggest Price Target Changes For Monday
May 09, 2022
Tickers
CI
EPAM
GH
K
Tags
Pre/Market Outlook
Price Target Changes
SPCE
From
Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
May 05, 2022
Tickers
ABUS
AGIO
ALDX
ARGX
Tags
JAZZ
Contracts
INCY
From
Benzinga
Earnings Preview For Intellia Therapeutics
May 04, 2022
Tickers
NTLA
Tags
Market News
NTLA
Earnings
From
Benzinga
How To Attend Intellia Therapeutics Q1 2022 Earnings Conference Call
May 02, 2022
Tickers
NTLA
Tags
Market News
BZI/CONF
Benzinga
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2022
April 28, 2022
Tickers
ACHR
ALL
AM
ARVN
Tags
FIXX
VRM
WAB
From
Benzinga
4 Analysts Have This to Say About Intellia Therapeutics
April 28, 2022
Tickers
NTLA
Tags
NTLA
BZI/AAR
Analyst Ratings
From
Benzinga
Stocks That Hit 52-Week Lows On Thursday
April 21, 2022
Tickers
HLBZ
HNST
HYFM
HYRE
Tags
TPHS
Trading Ideas
LSF
From
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
April 20, 2022
Tickers
ACLX
ADVM
AFCG
ALLK
Tags
RVSN
IVR
CDAK
From
Benzinga
3 Top Biotech Stocks Ready for a Bull Run
April 20, 2022
Tickers
BNTX
NTLA
PFE
REGN
Tags
BAYR/Y
NTLA
BNTX
From
Motley Fool
3 Ominous Reasons to Avoid This Biotech Pioneer
April 19, 2022
Tickers
CRSP
EDIT
NTLA
Tags
EDIT
Recent Press Releases
Market News
From
Motley Fool
CRISPR Stocks Are Huge -- Here's Why They'll Get Even Bigger by 2030
April 13, 2022
Tickers
CRSP
EDIT
NTLA
VRTX
Tags
CRSP
Recent Press Releases
Market News
From
Motley Fool
Who Benefits From Amazon's Stock Split?
March 16, 2022
Tickers
AAPL
AMZN
BMBL
CMG
Tags
SQ
GS
CMG
From
Motley Fool
FDA Recommends At Least 15 years Of Follow-Up For Genome Editing Product Trials
March 15, 2022
Tickers
BLUE
NTLA
Tags
Biotech
Market News
BLUE
From
Benzinga
Here's How Much $100 Invested In Intellia Therapeutics 5 Years Ago Would Be Worth Today
March 15, 2022
Tickers
NTLA
Tags
BZI/POD
Market News
NTLA
From
Benzinga
Intellia's CRISPR-Engineered Cell Therapy Receives FDA Orphan Drug Tag For Bone Marrow Cancer
March 10, 2022
Tickers
NTLA
Tags
News
Briefs
General
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2022
March 07, 2022
Tickers
AAL
AU
AUGX
AZUL
Tags
NTLA
T
SGHC
From
Benzinga
63 Biggest Movers From Yesterday
March 04, 2022
Tickers
AEO
ANGH
APCX
ATNX
Tags
News
ORN
ANGH
From
Benzinga
Is Intellia a Good Gene-Editing Stock to Buy Now?
March 03, 2022
Tickers
NTLA
REGN
Tags
NTLA
REGN
Recent Press Releases
From
Motley Fool
Can Biotech Stocks Provide Crypto-Like Growth for Your Portfolio?
March 03, 2022
Tickers
BNTX
BTC
CRSP
ETH
Tags
BNTX
NTLA
BTC
From
Motley Fool
80 Biggest Movers From Yesterday
March 02, 2022
Tickers
ALBO
AMBA
AMLX
ANPC
Tags
Small Cap
NVIV
GDRX
From
Benzinga
44 Stocks Moving In Tuesday's Mid-Day Session
March 01, 2022
Tickers
AMBA
AREB
ATRA
ATXI
Tags
EHTH
AMBA
NTLA
From
Benzinga
Analyst Ratings For Intellia Therapeutics
March 01, 2022
Tickers
NTLA
Tags
Market News
NTLA
Analyst Ratings
From
Benzinga
The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution
March 01, 2022
Tickers
ABBV
AMRN
AMRS
AVID
Tags
EPZM
AVID
Earnings
From
Benzinga
Intellia Shares Updated Data On Gene Editing Durability In Rare Disease
March 01, 2022
Tickers
NTLA
REGN
Tags
Health Care
REGN
Benzinga
From
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 28, 2022
Tickers
ATXI
BIMI
CKPT
FGEN
Tags
HRTX
Benzinga
Movers
From
Benzinga
This new competitor to the ARK Innovation ETF focuses on disruptive companies but aims to reduce volatility
February 28, 2022
Tickers
AMZN
ARKK
BLL
COIN
Tags
ZM
INNO
BLL
From
MarketWatch
The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight
February 27, 2022
Tickers
ACAD
ACLX
AMRN
AMRS
Tags
FULC
KALV
EVFM
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2022
February 18, 2022
Tickers
ADTH
API
ATUS
BEKE
Tags
FATH
ATUS
VTVT
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.